BDBM370229 US10233188, Example 116::US10800783, Example 116

SMILES: Cc1cc2cnc(NC3CCN(CC3)S(=O)(=O)CC3CC3)nc2n([C@@H]2CCC[C@@]2(C)O)c1=O

InChI Key: InChIKey=PKXRYTDXRPPJDM-AUSIDOKSSA-N

Data: 4 KI

Find this compound or compounds like it in BindingDB or PDB:

Substructure Similarity at least:  must be >=0.5 Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 4 hits for monomerid = 370229   

Target/Host (Institution)	Ligand	Target/Host Links	Ligand Links	Trg + Lig Links	Ki nM	ΔG° kcal/mole	IC50 nM	Kd nM	EC50/IC50 nM	koff s-1	kon M-1s-1	pH	Temp °C
CDK2/CycE (Homo sapiens (Human))	BDBM370229 (US10233188, Example 116 | US10800783, Example 116) Show SMILES Cc1cc2cnc(NC3CCN(CC3)S(=O)(=O)CC3CC3)nc2n([C@@H]2CCC[C@@]2(C)O)c1=O |r| Show InChI InChI=1S/C23H33N5O4S/c1-15-12-17-13-24-22(26-20(17)28(21(15)29)19-4-3-9-23(19,2)30)25-18-7-10-27(11-8-18)33(31,32)14-16-5-6-16/h12-13,16,18-19,30H,3-11,14H2,1-2H3,(H,24,25,26)/t19-,23-/m1/s1	PDB UniProtKB/SwissProt UniProtKB/TrEMBL antibodypedia antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	0.150	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Pfizer Inc. US Patent					Assay Description The purpose of the CDK2/Cyclin E1 assay is to evaluate the inhibition (% inhibition, Kiapp and Ki values) of small molecule inhibitors by using a flu...				US Patent US10800783 (2020)
					More data for this Ligand-Target Pair
CDK2/CycE (Homo sapiens (Human))	BDBM370229 (US10233188, Example 116 | US10800783, Example 116) Show SMILES Cc1cc2cnc(NC3CCN(CC3)S(=O)(=O)CC3CC3)nc2n([C@@H]2CCC[C@@]2(C)O)c1=O |r| Show InChI InChI=1S/C23H33N5O4S/c1-15-12-17-13-24-22(26-20(17)28(21(15)29)19-4-3-9-23(19,2)30)25-18-7-10-27(11-8-18)33(31,32)14-16-5-6-16/h12-13,16,18-19,30H,3-11,14H2,1-2H3,(H,24,25,26)/t19-,23-/m1/s1	PDB UniProtKB/SwissProt UniProtKB/TrEMBL antibodypedia antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	0.150	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
CNRS					Assay Description The purpose of the CDK2/Cyclin E1 assay is to evaluate the inhibition (% inhibition, Kiapp and Ki values) of small molecule inhibitors by using a flu...				J Med Chem 45: 1477-86 (2002) BindingDB Entry DOI: 10.7270/Q2FX7CSG
					More data for this Ligand-Target Pair
CDK6/Cyclin D1 (Homo sapiens (Human)-Mus musculus (mouse))	BDBM370229 (US10233188, Example 116 | US10800783, Example 116) Show SMILES Cc1cc2cnc(NC3CCN(CC3)S(=O)(=O)CC3CC3)nc2n([C@@H]2CCC[C@@]2(C)O)c1=O |r| Show InChI InChI=1S/C23H33N5O4S/c1-15-12-17-13-24-22(26-20(17)28(21(15)29)19-4-3-9-23(19,2)30)25-18-7-10-27(11-8-18)33(31,32)14-16-5-6-16/h12-13,16,18-19,30H,3-11,14H2,1-2H3,(H,24,25,26)/t19-,23-/m1/s1	PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt UniProtKB/TrEMBL B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	0.210	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Pfizer Inc. US Patent					Assay Description The purpose of the CDK6/Cyclin D1 assay is to evaluate the inhibition (% inhibition, Kiapp and Ki values) in the presence of small molecule inhibitor...				US Patent US10800783 (2020)
					More data for this Ligand-Target Pair
CDK6/Cyclin D1 (Homo sapiens (Human)-Mus musculus (mouse))	BDBM370229 (US10233188, Example 116 | US10800783, Example 116) Show SMILES Cc1cc2cnc(NC3CCN(CC3)S(=O)(=O)CC3CC3)nc2n([C@@H]2CCC[C@@]2(C)O)c1=O |r| Show InChI InChI=1S/C23H33N5O4S/c1-15-12-17-13-24-22(26-20(17)28(21(15)29)19-4-3-9-23(19,2)30)25-18-7-10-27(11-8-18)33(31,32)14-16-5-6-16/h12-13,16,18-19,30H,3-11,14H2,1-2H3,(H,24,25,26)/t19-,23-/m1/s1	PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt UniProtKB/TrEMBL B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	0.210	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
CNRS					Assay Description The purpose of the CDK6/Cyclin D1 assay is to evaluate the inhibition (% inhibition, Kiapp and Ki values) in the presence of small molecule inhibitor...				J Med Chem 45: 1477-86 (2002) BindingDB Entry DOI: 10.7270/Q2FX7CSG
					More data for this Ligand-Target Pair